| UniProt ID | LOXL4_HUMAN | |
|---|---|---|
| UniProt AC | Q96JB6 | |
| Protein Name | Lysyl oxidase homolog 4 | |
| Gene Name | LOXL4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 756 | |
| Subcellular Localization | Secreted, extracellular space . | |
| Protein Description | May modulate the formation of a collagenous extracellular matrix.. | |
| Protein Sequence | MAWSPPATLFLFLLLLGQPPPSRPQSLGTTKLRLVGPESKPEEGRLEVLHQGQWGTVCDDNFAIQEATVACRQLGFEAALTWAHSAKYGQGEGPIWLDNVRCVGTESSLDQCGSNGWGVSDCSHSEDVGVICHPRRHRGYLSETVSNALGPQGRRLEEVRLKPILASAKQHSPVTEGAVEVKYEGHWRQVCDQGWTMNNSRVVCGMLGFPSEVPVDSHYYRKVWDLKMRDPKSRLKSLTNKNSFWIHQVTCLGTEPHMANCQVQVAPARGKLRPACPGGMHAVVSCVAGPHFRPPKTKPQRKGSWAEEPRVRLRSGAQVGEGRVEVLMNRQWGTVCDHRWNLISASVVCRQLGFGSAREALFGARLGQGLGPIHLSEVRCRGYERTLSDCPALEGSQNGCQHENDAAVRCNVPNMGFQNQVRLAGGRIPEEGLLEVQVEVNGVPRWGSVCSENWGLTEAMVACRQLGLGFAIHAYKETWFWSGTPRAQEVVMSGVRCSGTELALQQCQRHGPVHCSHGGGRFLAGVSCMDSAPDLVMNAQLVQETAYLEDRPLSQLYCAHEENCLSKSADHMDWPYGYRRLLRFSTQIYNLGRTDFRPKTGRDSWVWHQCHRHYHSIEVFTHYDLLTLNGSKVAEGHKASFCLEDTNCPTGLQRRYACANFGEQGVTVGCWDTYRHDIDCQWVDITDVGPGNYIFQVIVNPHYEVAESDFSNNMLQCRCKYDGHRVWLHNCHTGNSYPANAELSLEQEQRLRNNLI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 140 | Phosphorylation | HPRRHRGYLSETVSN CCCCCCCCCCHHHHH | 13.65 | 26503514 | |
| 146 | Phosphorylation | GYLSETVSNALGPQG CCCCHHHHHHHCCCC | 24.65 | 26503514 | |
| 172 | Phosphorylation | LASAKQHSPVTEGAV HHHHHCCCCCCCCCE | 20.69 | 24275569 | |
| 175 | Phosphorylation | AKQHSPVTEGAVEVK HHCCCCCCCCCEEEE | 31.89 | 24275569 | |
| 183 | Phosphorylation | EGAVEVKYEGHWRQV CCCEEEEECCCCEEE | 32.11 | 24275569 | |
| 198 | N-linked_Glycosylation | CDQGWTMNNSRVVCG ECCCCCCCCCEEEEE | 35.63 | UniProtKB CARBOHYD | |
| 304 | Phosphorylation | TKPQRKGSWAEEPRV CCCCCCCCCCCCCCE | 26.58 | 29507054 | |
| 383 | Phosphorylation | SEVRCRGYERTLSDC HEEECCCCCCCHHCC | 5.27 | 17081983 | |
| 475 | Phosphorylation | LGFAIHAYKETWFWS CEEEEEEEECCEECC | 8.66 | - | |
| 629 | N-linked_Glycosylation | HYDLLTLNGSKVAEG EEEEEEECCCCCCCC | 47.67 | UniProtKB CARBOHYD | |
| 640 | Phosphorylation | VAEGHKASFCLEDTN CCCCCCCEEECCCCC | 22.69 | 29507054 | |
| 674 | "2',4',5'-topaquinone" | TVGCWDTYRHDIDCQ EECEECCCCCCCCCE | 11.95 | - | |
| 674 | Other | TVGCWDTYRHDIDCQ EECEECCCCCCCCCE | 11.95 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LOXL4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LOXL4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LOXL4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| APOE_HUMAN | APOE | physical | 21163940 | |
| LONM_HUMAN | LONP1 | physical | 21163940 | |
| RD23A_HUMAN | RAD23A | physical | 21163940 | |
| PCH2_HUMAN | TRIP13 | physical | 19060904 | |
| KDM1A_HUMAN | KDM1A | physical | 23455924 | |
| ANM6_HUMAN | PRMT6 | physical | 23455924 | |
| SUV91_HUMAN | SUV39H1 | physical | 23455924 | |
| TCPW_HUMAN | CCT6B | physical | 26186194 | |
| SPS2_HUMAN | SEPHS2 | physical | 26186194 | |
| SPS2_HUMAN | SEPHS2 | physical | 28514442 | |
| TCPW_HUMAN | CCT6B | physical | 28514442 | |
| TCPZ_HUMAN | CCT6A | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-383, AND MASSSPECTROMETRY. | |